Aktie 000766 TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Aktien

000766

CNE000000735

000766

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
17,03 CNY +0,35 % Intraday Chart für Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd +1,25 % -14,59 %
22.04. Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
18.04. Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) added to S&P Global BMI Index
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei completed the acquisition of a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei agreed to acquire a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Approves Board Elections
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) dropped from S&P Global BMI Index
Tonghua Golden-Horse Pharmaceutical Industry Co, cancelled the acquisition of Jixi Jikuang Hospital Co., Ltd. and Shuangyashan Shuangkuang Hospital Co., Ltd. from Suzhou Industrial Park Dexin Yili Investment Center (Limited Partnership) and others.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 000766 Aktie
  4. Nachrichten Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
  5. Andere Sprachen